chrisvoncsefalvay/vaers-outcomes huggingface dataset:
arm pain; Headache; Chest pain when taking breath; This is a spontaneous report received from a contactable consumer (patient). A 15-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Lot number: EW0182, Expiration date: Aug2021) via an intramuscularly administered in right arm on 19May2021 at 09:00 AM (age at the time of vaccination 15 years old) as DOSE 1, SINGLE and second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: solution for injection, Lot number: EW0217, Expiration date: Sep2021) via an intramuscularly administered in left arm on 09Jun2021 at 09:00 (age at the time of vaccination 15 years old) as DOSE 2, SINGLE for covid-19 immunization at school/student health clinic. The patient's medical history included neutropenia from an unknown date and unknown if ongoing. Prior vaccinations within 4 weeks included allergy shot via intramuscular route, administered in arm right on an unspecified date in May2021. No covid tested post vaccination. No other vaccine in four weeks. No covid prior vaccination. The patient's concomitant medications included ergocalciferol (VIT D), calcium and macrogol 3350 (MIRALAX). The patient experienced chest pain when taking breath on 19May2021 at 11:15 AM, headache on 19May2021 at 02:00 PM and arm pain on an unspecified date. He did not receive treatment for adverse event chest pain and he received treatment of tylenol via oral liquid from 19May2021 to 21May2021 for arm pain and from 09Jun2021 to 11Jun2021 for headache orally. The outcome of events was unknown.  Follow-up attempts completed. No further information expected.
Clonic movements of both upper extremities for about 10sec; noted to stop movements suddenly & look up in a fixed fashion & stare; dx titubation of head; spasticity of rt hand; weakness lt side of face;
Patient received the vaccine on 09/30/21 and developed a fever the following day on 10/01/21 which caused profuse sweating. EMS was called to the home on 10/02/21 and the fever broke that following evening. Since the fever has resolved, patient has now been experiencing a constant runny nose and post-nasal drip causing a sore throat.
Was given a pediatric bivalent shot made for age group 5yr-11yr when supposed to have gotten 3rd dose of the shot meant for ages 6mo-4yr
pt recvd vax; 22jul95 devel fever & greater than 100 vesicular type lesions; MD dx him as having chicken pox although pt had no known exposure to chicken pox;
within 30 minutes of receiving the first dose her left leg was hurting with muscle pains and says she could not walk without assistance for 3 days; says she could not walk without assistance; within 30 minutes of receiving the first dose her left leg was hurting with muscle pains and says she could not walk without assistance for 3 days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (within 30 minutes of receiving the first dose her left leg was hurting with muscle pains and says she could not walk without assistance for 3 days), MOBILITY DECREASED (says she could not walk without assistance) and MYALGIA (within 30 minutes of receiving the first dose her left leg was hurting with muscle pains and says she could not walk without assistance for 3 days) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017E21A) for COVID-19 vaccination.     The patient's past medical history included Polio.    On 13-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (within 30 minutes of receiving the first dose her left leg was hurting with muscle pains and says she could not walk without assistance for 3 days), MOBILITY DECREASED (says she could not walk without assistance) and MYALGIA (within 30 minutes of receiving the first dose her left leg was hurting with muscle pains and says she could not walk without assistance for 3 days). The patient was treated with TRAMADOL for Adverse event, at a dose of 1 dosage form and IBUPROFEN for Adverse event, at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (within 30 minutes of receiving the first dose her left leg was hurting with muscle pains and says she could not walk without assistance for 3 days), MOBILITY DECREASED (says she could not walk without assistance) and MYALGIA (within 30 minutes of receiving the first dose her left leg was hurting with muscle pains and says she could not walk without assistance for 3 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication information was provided by the reporter.  The patient also reported treatment of "ibuprofen with something else in it".
Hospitalization: admitted 7/18/2022; discharged 8/22/2022 Presentation to the ED: admitted for acute renal failure on chronic disease stage IV with probable tubular necrosis, anemia of chronic kidney disease, hyperkalemia, uremia, symptomatic anemia, type 2 myocardial infarction/elevated troponin, microscopic hematuria, severe protein energy malnutrition.  COVID-19 + date: 7/25/22.  Treatment: No indications for COVID-19 specific therapy. Patient was asymptomatic.  Discharge to: Home-Health Care Svc
Patient did not report symptoms until I called about coming in to receive 2nd COVID vaccine. Stated her cheeks got very hot, facial flushing on the way home from the clinic after sitting in the clinic for 30 mins on 4/2/2021
Swelling. Rash. Headache. Symptoms started the first evening of 9/27 and continued escalating through 10/13 when Dr. prescribed prednisone for me. I was diagnosed - Vasculitis all over.
Rapid heartbeat for six hours.  4 chewable 81 mg. aspirins
Soreness in arm for first 2 days. Low back pain and abdominal cramping for 1 day on day vaccine received. Fatigue for 1 day on day after receiving vaccine.
Sudden onset vertigo (resolving in a few minutes) followed by headache, ringing in ears, and cognitive difficulties continuing since then (over 5 weeks as of now).     Supplements (B, D, Zinc, C), migraine medicine, tylenol, NSAIDS).
my kidneys went from being in no pain to a 10/10 on the pain scale 1 week after receiving the vaccine/ pain dissipated down to an 8/10 after 3 months; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 40 year-old male patient received bnt162b2 (BNT162B2), administered in arm left, administration date 13Mar2021 (Lot number: EN6206) at the age of 40 years as dose 2, single for covid-19 immunisation. Patient had an underlying disease. Relevant medical history included: "Polycystic kidney disease" (unspecified if ongoing); "Type II diabetes" (unspecified if ongoing). No covid prior vaccination. No other vaccine in four weeks. No known allergies. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: EN6200, Brand=Pfizer, Product=COVID 19), administration date: 20Feb2021, for COVID-19 immunization. He did not have an adverse reaction to the first vaccine.  The following information was reported: RENAL PAIN (disability) with onset 20Mar2021, outcome "not recovered", described as "my kidneys went from being in no pain to a 10/10 on the pain scale 1 week after receiving the vaccine/ pain dissipated down to an 8/10 after 3 months". One week after receiving his second dose of the vaccine his kidneys went from being in no pain to a 10 10 on the pain scale 1 week after receiving the vaccine. That pain dissipated down to an 8 10 after 3 months but never resolved. He was required to get the booster to continue attending school. 1 day after receiving the vaccine his pain was back to a 10+ to the point he was shaking from the pain. That had still not resolved 3 weeks later. Patient was covid tested post vaccination. The patient underwent the following laboratory tests and procedures: pain assessment: 10/10, notes: on the pain scale 1 week after receiving the vaccine; 8/10, notes: dissipated down to a 8/10 after 3 months but never resolved; sars-cov-2 test: negative, notes: Covid test type: Nasal Swab, post vaccination. Therapeutic measures were taken as a result of renal pain. Adverse event treatment: Nephrologist stated no treatment available.
Admission reviewed.  Essentially here with weakness and assisted living did not feel they could accommodate her needs.  Vital signs stable through the night and she remains on room air.  Plan had been for outpatient monoclonal antibody infusion and this was ordered inpatient.
She did not have any reactions initially, but noticed the morning after the vaccine that her regular cup of coffee did not taste good.  She then had a rash that started on the left side of her neck, went towards the back now.  This started a few days after the vaccine, all on the left side.  She also got a cold sore on her lip which she had all the time as a child, but not as an adult, which has pretty much resolved.  She has been cold, chills and some dizzy spells.  She did get a bump on her head concussion in December.  One day last week she just stayed on the sofa with a blanket due to feeling poorly.  3 days ago on her back by her shoulder blade an area has been really sore.  She did take some Tylenol for the back pain which did not help so she stopped this.   She did not call her doctor.    The rash is still there but not as intense.  It has not itched, but she has felt it.
Fever, chills (102.0 temp). Clear liquids, Tylenol 500mg-650mg every 6 hrs.
Rash to left side x1.5 weeks- spreading to right side on legs from knee up. COVID shot 4/10 2nd-Pfizer. Rash is red, blotchy, raised, itchy, hot, irritating.
This spontaneous report was received from a healthcare worker referring to a 2 month old twin patient of unknown gender who on 16-JUL-2014, was vaccinated with 1st dose of ROTATEQ (lot # reported as K001198. expiration date 25-OCT-2015). On 16-JUL-2014, immediately after vaccination the patient developed vomiting and diarrhea. The mother clarified to healthcare worker by stating spitting up more and up 6 episodes of diarrhea. The outcome of vomiting and diarrhea was unknown. This is one of three reports from the same reporter source.  Additional information has been requested.
At 4pm in afternoon I was informed that patient felt light-headed and had blurred vision at work. He was taken to the hospital by ambulance where he is currently being evaluated.
right arm started twitching / right eye twitches; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 27 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 16Apr2021 (Lot number: EW0153) at the age of 27 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. The following information was reported: MUSCLE TWITCHING (non-serious) with onset 16Apr2021, outcome "not recovered", described as "right arm started twitching / right eye twitches". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of muscle twitching. Clinical course: The patient got the first shot of Pfizer vaccine 7 days ago and seconds after, his right arm started twitching and has not stopped twitching. It was persisting and was getting a little bit worse and also right eye twitches as well. He stated that he does not have a doctor or anything else and has not seen a doctor for a while. Patient was scheduled for the 2nd shot on 07May 2021.  No follow-up attempts are possible. No further information is expected.
Patient received vaccine and developed a 3 cm red wheal about 6 cm below where she received the vaccine. The lesion was red and itchy but not warm. She otherwise felt fine with no other symptoms. We gave her cetirizine 10 mg about 15 min after the event since it was still itching. She was observed for an additional 20 minutes. we spoke to her through the interpreter and she felt fine and wanted to leave.
pt recvd vax & following vax had joint pain (arthralgia); pt was seen by MD; sx are unresolved; also knee pain;
This spontaneous report as received from a healthcare worker refers to a patient of unknown age and gender. On 03-JUN-2016, the patient was vaccinated with improperly stored ROTATEQ (dose and frequency were not reported). The reporter did not know which dose from which lot was administered to the patient and the possible ROTATEQ lot# administered was: lot # L029618 (expiry date: 20-MAY-2017), L038534 (expiry date: 19-AUG-2017) and/or M004508 (expiry date: 29-JUN-2017). No adverse effects were reported. No product quality complaint (PQC) was reported for ROTATEQ. This is one of the two reports from the same reporter. Additional information has been requested.
Patient woke the morning after getting the FLUMIST (16hrs) with swollen eyes, nasal passages, mouth, throat localized mucous membranes, nose, mouth with slight wheezing remote history Reactive Airway Disease. Used BENADRYL.
Information has been received on 01/30/2002 from a published literature article regarding a 12 year old female. In 1994, four years after receiving her 5th dose of DTP (manufacturer unknown), she was hospitalized with a diagnosis of tetanus. The reporter indicated that the child received a puncture wound after stepping on a rake. Treatment included tetanus immune globulin administered 5 to 9 days post onset of symptoms. She was discharged after 1 day and received an additional 6 weeks of home care.
This spontaneous report as received from a registered nurse via field representative refers to a female patient of unknown age. In 2008 the patient was vaccinated with the third dose of GARDASIL dose, lot # and route unknown. The representative stated that she did know that the patient received the 1st and 2nd shots of GARDASIL, but specific dates were unknown. On an unknown date after receiving the 3rd shot of the GARDASIL vaccine the patient experienced abdominal pain. The outcome of abdominal pain was unknown. The relatedness between abdominal pain and GARDASIL was unknown. Additional information has been requested.
Information has been received from a registered nurse concerning an 83 year old male with a history of prostate condition who on 10/19/05 was vaccinated SC with a second dose of 0.5ml pneumococcal 23v polysaccharide vaccine (lot # 650649/0790P). Concomitant therapy included an unspecified diuretic. On the evening of 10/19/05, the patient developed pain at the injection site. On 10/20/05 the patient's arm felt heavy, hot, red, and swollen. On 10/22/05 the patient continued to get worse so his family took him to the emergency room where he received IV antibiotics for 3 days and oral antibiotics for 7 days after that. The nurse reported that the patient was hospitalized but received the IV antibiotics as an outpatient. On 11/21/05 the patient reported to the nurse that he felt he had fully recovered. It was noted that the patient had received a first dose of pneumococcal 23v polysaccharide vaccine 20 years ago when he was in his 60s. No product quality complaint was involved. The nurse felt that pain at injection site and the arm felt heavy, hot, red and swollen were considered to be other important medical events because the patient told her that the ER physicians told him that if he had not come into the ER he might have lost his arm. Additional information has been requested.
Pt was seen for a well visit around 3pm on 7/21/06 provider ordered vaccines. Vaccines were administered and pt tolerated well. The following morning pt awoke with lot of itching right leg became red, swollen and warm to touch. Mom brought pt to the DR on 7/24/06. Right leg noted to have small blister type rash. Very swollen app 10" in diameter red, hard and feverish. Denies pain.
HIVES ALL OVER THE AREA FROM THE ELBOW TO THE SHOULDER, SEVERE HEAT SURROUNDING THE INJECTION SITE, SWELLING
Recurring bouts of fever, aches.  Pain when taking deep breath.  eventually shortness of breath and pressure high in chest. Diagnosis : Pericardial Effusion. Treatment : Surgery to drain fluid. install drain. install pericardial window.  5 days in hospital.
1/21/21 inoculation    1/22-26 sore arm 1/29/21 awoke with 3 inch red, itchy arm at inoculation site. Sent a snapshot to my dermatologist. He told me to apply ice or steroid cream, and to contact my doctor if I develop fever. 1/30/21  Rash doubled in size to 6 inches;took over 2 weeks to subside! Pinkness still remains as of today 2/15/21. My 2nd shot is scheduled 2/18/21. Arm rash still slightly visable today, 2/15/21
Pt fully vaccinated with Janssen J&J COVID-19 Vaccine on 3/31/2021.  Pt came in for same day surgical procedure on 7/26/2021.  Pt was asymptomatic, but protocol is to test prior to procedure.  Test came back positive, procedure was canceled so pt could isolate for 10 days.  As of now, pt has still not reported any symptoms.
Skin rash started occurring within hours... thought it was eczema but after a few days realized my normal eczema prescription was not working..rash then gradually became much worse and continues now 3 weeks later
This spontaneous report was received from a registered nurse refers to an unknown number of patients of unknown age. On an unknown date, the patients were vaccinated with improperly stored doses of ZOSTAVAX, lot # L021602 10-SEP-2016, L025001 06-OCT-2016, L036445 22-DEC-2016, L037797 30-DEC-2016, L048452 01-MAR-2017, M010472 01-JUN-2017. No adverse effects were reported. Temperature -13.3 degrees centigrade, time 10 minutes. There was no previous exposure. Additional information has been requested.
Started having tingling/numbness in both hands at the finger tips except the thumbs Narrative:
Pt complained of palpitations. Interpreter was called and staff gave fluids, crackers, ice packs and took vital signs. VS: HR 120 R21 BP 196/120 O2 99.  Instructed patient to take deep breaths. Breathing techniques initiated. Heart rate went from 120 bpm to 89 bpm. Blood pressure remains elevated and complained of chest pain (midsternal) at 3:50pm.  EMS was called at 4:24 pm and arrived at 4:35pm . Patient denies any history of hyper tension. denied headache, SOB, blurred vision.  After EMS arrived EKG was initiated and vitals were taken again. BP 200/103 and normal sinus rhythm.  BP  came down  to 186/108 HR 88. was transported to 3 gold street Hospital. Left with EMS at 4:56 without any signs of distress.
localized cellulitis; redness at injection site; Sweeling at injection site; bruising; Skin Breakdown; This serious case was reported by a physician via sales rep and described the occurrence of cellulitis in a 61-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced cellulitis (Verbatim: localized cellulitis) (serious criteria GSK medically significant), injection site erythema (Verbatim: redness at injection site), injection site swelling (Verbatim: Sweeling at injection site), contusion (Verbatim: bruising) and skin breakdown (Verbatim: Skin Breakdown). The outcome of the cellulitis, injection site erythema, injection site swelling, contusion and skin breakdown were not reported.   It was unknown if the reporter considered the cellulitis, injection site erythema, injection site swelling, contusion and skin breakdown to be related to Arexvy.     It was unknown if the company considered the cellulitis, injection site erythema, injection site swelling, contusion and skin breakdown to be related to Arexvy.   Additional Information: GSK receipt date: 28-OCT-2023 The physician reported a patient returned within 2 weeks with bruising, redness, and swelling at injection site. Within 4 weeks, skin breakdown had occurred, and physician was concerned about localized cellulitis. The reporter did not consent to follow up.
Breakthrough positive covid case 7 weeks after booster; Breakthrough positive covid case 7 weeks after booster; booster; is_pregnant: Yes; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group.  An adult female patient (pregnant) received bnt162b2 (BNT162B2), administration date 2021 (Lot number: EW0196) as dose 3 (booster), single, (Batch/Lot number: unknown) as dose 1, single and (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: COVID-19 (medically significant), DRUG INEFFECTIVE (medically significant) all with onset 2021, outcome "not recovered" and all described as "Breakthrough positive covid case 7 weeks after booster"; IMMUNISATION (medically significant) with onset 2021, outcome "unknown", described as "booster"; MATERNAL EXPOSURE DURING PREGNANCY (medically significant) with onset 2021, outcome "unknown", described as "is_pregnant: Yes". The patient underwent the following laboratory tests and procedures: sars-cov-2 test: positive, notes: if covid tested post vaccination: Yes. Therapeutic measures were not taken as a result of covid-19, drug ineffective.  Clinical course: Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19.  The lot number for bnt162b2 was not provided and will be requested during follow up.
2 days post vaccine, EE had hard, warm area at injection site-did not report 5/20/08.  Referred to occmed MD for F/U.  Tx with BENADRYL & LIDEX cream.  Off work x 1 day to take meds.  MD thinks Rx secondary to NEOMYCIN sensitivity.  *EE did not reveal this at time of vaccine.
Bloody nose, sneezing, coughing, nasal drainage and joint aches....still persistent 11/13/2011.
pt recv 2nd dose of vax 31JUL95 & 4AUG95 pt devel a fever of 102 & diarrhea;By 6AUG95 pt recovered;lab eval revealed that pt failed to seroconvert;
10/26/05 9:30pm Mother called stating daughter had flu shot today. Now c/o eyes red and swollen, skin is slightly blotchy. Mother feels child is having allergic reaction to vaccine. Benadryl given. 10/27/05 10:30 am Mother called back, states child is much better. Subsequent immunocap allergy testing plus egg white allergy.
pt recvd 3 doses of Engerix-B p/last dose titer was checked & determined to be neg;
CRAMPS ON LEGS; BODY ACHES; LETHARGIC; HEADACHE ON SIDES OF TEMPLES; SORE RIGHT ARM; BUMP AT INJECTION SITE; This spontaneous report received from a patient concerned a 31 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known drug allergies, patient had not reported any medical conditions. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 12-APR-2021 for prophylactic vaccination. No concomitant medications were reported.  On 12-APR-2021, the subject experienced sore right arm. On 12-APR-2021, the subject experienced bump at injection site. On 14-APR-2021, the subject experienced body aches. On 14-APR-2021, the subject experienced lethargic. On 14-APR-2021, the subject experienced headache on sides of temples. On 15-APR-2021, the subject experienced cramps on legs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body aches, lethargic, and sore right arm on 15-APR-2021, and had not recovered from bump at injection site, headache on sides of temples, and cramps on legs. This report was non-serious.